Evidence map›Paper›PMID 35019680›Full record

ArticleMicrobiology spectrum2022

Jerveratrum-Type Steroidal Alkaloids Inhibit β-1,6-Glucan Biosynthesis in Fungal Cell Walls.

Karen Kubo, Kaori Itto-Nakama, Shinsuke Ohnuki, Yoko Yashiroda, Sheena C Li, Hiromi Kimura, Yumi Kawamura, Yasuhiro Shimamoto, Ken-Ichi Tominaga, Daisuke Yamanaka and 5 more

Open access · goldAbstract read
In one paragraph

Article in Microbiology spectrum, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
5.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. HTD1265 Disrupts GimC-Dependent Cellular Processes inPathogens (Basel, Switzerland) · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Analysis of Biochemical and Genetic Variability ofJournal of fungi (Basel, Switzerland) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 2 countries.

Karen KuboDepartment of Integrated Biosciences, Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa, Chiba, Japan.
Kaori Itto-NakamaDepartment of Integrated Biosciences, Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa, Chiba, Japan.ORCID 0000-0002-9416-6612
Shinsuke OhnukiDepartment of Integrated Biosciences, Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa, Chiba, Japan.ORCID 0000-0001-6254-081X
Yoko YashirodaRIKENgrid.7597.c Center for Sustainable Resource Science, Wako, Saitama, Japan.
Sheena C LiRIKENgrid.7597.c Center for Sustainable Resource Science, Wako, Saitama, Japan.
Hiromi KimuraRIKENgrid.7597.c Center for Sustainable Resource Science, Wako, Saitama, Japan.
Yumi KawamuraRIKENgrid.7597.c Center for Sustainable Resource Science, Wako, Saitama, Japan.
Yasuhiro ShimamotoInterdisciplinary Research Center for Catalytic Chemistry, National Institute of Advanced Industrial Science and Technology (AIST), Tsukuba, Ibaraki, Japan.
Ken-Ichi TominagaAIST-UTokyo Advanced Operando-Measurement Technology Open Innovation Laboratory (OPERANDO-OIL), National Institute of Advanced Industrial Science and Technology (AIST), Kashiwa, Chiba, Japan.
Daisuke YamanakaLaboratory for Immunopharmacology of Microbial Products, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, Hachioji, Tokyo, Japan.
Yoshiyuki AdachiLaboratory for Immunopharmacology of Microbial Products, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, Hachioji, Tokyo, Japan.
Shinichiro TakashimaResearch & Development Division, SDS Biotech, Midorigahara, Tsukuba, Ibaraki, Japan.
Yoichi NodaGraduate School of Agricultural and Life Sciences, The University of Tokyo, Bunkyo-ku, Tokyo, Japan.
Charles BooneRIKENgrid.7597.c Center for Sustainable Resource Science, Wako, Saitama, Japan.ORCID 0000-0002-3542-6760
Yoshikazu OhyaDepartment of Integrated Biosciences, Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa, Chiba, Japan.ORCID 0000-0003-0837-1239
National Institute of Advanced Industrial Science and Technology · JPRIKEN Center for Sustainable Resource Science · JPThe University of Tokyo · JPSDS Biotech (Japan) · JPTokyo University of Pharmacy and Life Sciences · JPUniversity of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The limited number of available effective agents necessitates the development of new antifungals. We report that jervine, a jerveratrum-type steroidal alkaloid isolated from Veratrum californicum, has antifungal activity. Phenotypic comparisons of cell wall mutants, K1 killer toxin susceptibility testing, and quantification of cell wall components revealed that β-1,6-glucan biosynthesis was significantly inhibited by jervine. Temperature-sensitive mutants defective in essential genes involved in β-1,6-glucan biosynthesis, including

Indexed as

AlkaloidsAntifungal Agentsbeta-GlucansCandidaCell WallFungiHumansMycosesPlant ExtractsVeratrumAlkaloidsAntifungal Agentsbeta-1,6-glucanbeta-GlucansPlant Extracts6-glucanantifungalCandidajervineKre6Skn1β-1

Identifiers

PMID35019680
PMCPMC8754110
OpenAlexW4205806783

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.